UBS AM’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.4M | Buy |
142,136
+47,706
| +51% | +$1.14M | ﹤0.01% | 1896 |
|
|
2025
Q1 | $2.35M | Sell |
94,430
-10,425
| -10% | -$259K | ﹤0.01% | 1917 |
|
|
2024
Q4 | $1.98M | Buy |
104,855
+21,781
| +26% | +$410K | ﹤0.01% | 2053 |
|
|
2024
Q3 | $1.25M | Sell |
83,074
-22,839
| -22% | -$344K | ﹤0.01% | 2282 |
|
|
2024
Q2 | $3.03M | Buy |
105,913
+55,777
| +111% | +$1.6M | ﹤0.01% | 1770 |
|
|
2024
Q1 | $1.46M | Hold |
50,136
| – | – | ﹤0.01% | 1831 |
|
|
2023
Q4 | $1.69M | Hold |
50,136
| – | – | ﹤0.01% | 1773 |
|
|
2023
Q3 | $1.54M | Buy |
50,136
+2,326
| +5% | +$71.4K | ﹤0.01% | 1743 |
|
|
2023
Q2 | $1.95M | Hold |
47,810
| – | – | ﹤0.01% | 1663 |
|
|
2023
Q1 | $1.95M | Buy |
47,810
+4,618
| +11% | +$188K | ﹤0.01% | 1663 |
|
|
2022
Q4 | $1.67M | Hold |
43,192
| – | – | ﹤0.01% | 1612 |
|
|
2022
Q3 | $2.3M | Sell |
43,192
-10,735
| -20% | -$571K | ﹤0.01% | 1529 |
|
|
2022
Q2 | $3.14M | Buy |
53,927
+525
| +1% | +$30.6K | ﹤0.01% | 1411 |
|
|
2022
Q1 | $4.08M | Buy |
53,402
+2,511
| +5% | +$192K | ﹤0.01% | 1448 |
|
|
2021
Q4 | $3.06M | Hold |
50,891
| – | – | ﹤0.01% | 1658 |
|
|
2021
Q3 | $2.85M | Hold |
50,891
| – | – | ﹤0.01% | 1673 |
|
|
2021
Q2 | $3.09M | Buy |
50,891
+3,680
| +8% | +$223K | ﹤0.01% | 1646 |
|
|
2021
Q1 | $3.31M | Sell |
47,211
-421
| -0.9% | -$29.5K | ﹤0.01% | 1527 |
|
|
2020
Q4 | $2.85M | Buy |
47,632
+3,425
| +8% | +$205K | ﹤0.01% | 1543 |
|
|
2020
Q3 | $2.66M | Buy |
44,207
+2,568
| +6% | +$154K | ﹤0.01% | 1429 |
|
|
2020
Q2 | $2.18M | Sell |
41,639
-6,038
| -13% | -$317K | ﹤0.01% | 1487 |
|
|
2020
Q1 | $1.6M | Sell |
47,677
-197
| -0.4% | -$6.61K | ﹤0.01% | 1505 |
|
|
2019
Q4 | $2.17M | Buy |
47,874
+241
| +0.5% | +$10.9K | ﹤0.01% | 1569 |
|
|
2019
Q3 | $1.81M | Buy |
47,633
+4,088
| +9% | +$156K | ﹤0.01% | 1650 |
|
|
2019
Q2 | $1.89M | Buy |
43,545
+7,562
| +21% | +$329K | ﹤0.01% | 1621 |
|
|
2019
Q1 | $1.37M | Buy |
35,983
+1,643
| +5% | +$62.5K | ﹤0.01% | 1689 |
|
|
2018
Q4 | $1.48M | Buy |
34,340
+4,983
| +17% | +$214K | ﹤0.01% | 1562 |
|
|
2018
Q3 | $1.44M | Hold |
29,357
| – | – | ﹤0.01% | 1643 |
|
|
2018
Q2 | $941K | Buy |
29,357
+3,426
| +13% | +$110K | ﹤0.01% | 1832 |
|
|
2018
Q1 | $808K | Buy |
25,931
+7,031
| +37% | +$219K | ﹤0.01% | 1855 |
|
|
2017
Q4 | $863K | Sell |
18,900
-5,564
| -23% | -$254K | ﹤0.01% | 1803 |
|
|
2017
Q3 | $919K | Buy |
24,464
+292
| +1% | +$11K | ﹤0.01% | 1743 |
|
|
2017
Q2 | $1.15M | Sell |
24,172
-151,120
| -86% | -$7.21M | ﹤0.01% | 1600 |
|
|
2017
Q1 | $7.99M | Buy |
175,292
+4,592
| +3% | +$209K | 0.01% | 932 |
|
|
2016
Q4 | $5.51M | Sell |
170,700
-21,390
| -11% | -$691K | 0.01% | 977 |
|
|
2016
Q3 | $6.57M | Sell |
192,090
-5,516
| -3% | -$189K | 0.01% | 969 |
|
|
2016
Q2 | $6.67M | Buy |
197,606
+64,284
| +48% | +$2.17M | 0.01% | 959 |
|
|
2016
Q1 | $7.06M | Sell |
133,322
-9,868
| -7% | -$523K | 0.01% | 938 |
|
|
2015
Q4 | $11M | Buy |
143,190
+41,354
| +41% | +$3.18M | 0.01% | 838 |
|
|
2015
Q3 | $4.19M | Buy |
101,836
+15,778
| +18% | +$649K | ﹤0.01% | 1122 |
|
|
2015
Q2 | $6.09M | Buy |
86,058
+59
| +0.1% | +$4.17K | 0.01% | 1015 |
|
|
2015
Q1 | $7.64M | Sell |
85,999
-500
| -0.6% | -$44.4K | 0.01% | 950 |
|
|
2014
Q4 | $7.67M | Buy |
86,499
+12,400
| +17% | +$1.1M | 0.01% | 942 |
|
|
2014
Q3 | $7.18M | Sell |
74,099
-700
| -0.9% | -$67.8K | 0.01% | 948 |
|
|
2014
Q2 | $6.87M | Sell |
74,799
-6,600
| -8% | -$606K | 0.01% | 962 |
|
|
2014
Q1 | $5.7M | Sell |
81,399
-3,900
| -5% | -$273K | 0.01% | 1008 |
|
|
2013
Q4 | $4.9M | Sell |
85,299
-86,900
| -50% | -$5M | 0.01% | 1014 |
|
|
2013
Q3 | $8.28M | Buy |
172,199
+11,800
| +7% | +$567K | 0.01% | 852 |
|
|
2013
Q2 | $4.65M | Buy |
+160,399
| New | +$4.65M | 0.01% | 975 |
|